Bumrungrad Hospital Public Co Limited/ADR

Bumrungrad Hospital Public Co Limited/ADR

Bumrungrad Hospital Public Company Limited was founded in 1980 and is headquartered in Bangkok, Thailand. The firm is publicly traded on the Stock Exchange of Thailand and offers its shares as American Depositary Receipts (ADRs) on Over-the-Counter markets. It operates one of the largest private hospitals in Southeast Asia, with a focus on medical tourism and specialized care. The company allocates capital toward hospital infrastructure, clinical technology, and strategic partnerships. As of 2023, its revenue streams come from inpatient and outpatient services across multiple specialties, including cardiology, orthopedics, and oncology. It also operates in locations such as Cambodia through subsidiaries, reflecting a regional footprint in Southeast Asia. The firm's investment posture favors operational capex over financial portfolio investment. As of 2023, Bumrungrad maintained a network of over 5,200 employees and treated approximately 1.1 million patients annually, per the firm's published annual report. It has not disclosed any asset management or family-office-related vehicles. The company is publicly owned, with no single controlling family or principal designation. In 2023, the firm reported net income of roughly 2.1 billion baht, per its financial statements. A structural differentiator is its ADR structure, which allows international investors access to Thai healthcare equity without direct foreign-exchange exposure. The company is an operating business, not a family office, and its capital allocation is dictated by corporate strategy rather than wealth management.